217 related articles for article (PubMed ID: 21149845)
41. Breed-related differences in altered BRCA1 expression, phenotype and subtype in malignant canine mammary tumors.
Im KS; Kim IH; Kim NH; Lim HY; Kim JH; Sur JH
Vet J; 2013 Mar; 195(3):366-72. PubMed ID: 22901454
[TBL] [Abstract][Full Text] [Related]
42. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.
Ahern TE; Bird RC; Bird AE; Wolfe LG
Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884
[TBL] [Abstract][Full Text] [Related]
43. Increased Derlin-1 expression in metastases of canine mammary adenocarcinomas.
Klopfleisch R; Schütze M; Linzmann H; Brunnberg L; Gruber AD
J Comp Pathol; 2010 Jan; 142(1):79-83. PubMed ID: 19632687
[TBL] [Abstract][Full Text] [Related]
44. Tumor-associated carbohydrate antigens: Sialyl Lea and T/Tn antigens in canine mammary tumors.
Nowak M; Madej J; Dziegiel P; Lopuszynski W; Rodo A; Ugorski M
Vet Pathol; 2009 Mar; 46(2):222-6. PubMed ID: 19261632
[TBL] [Abstract][Full Text] [Related]
45. Spontaneous mammary intraepithelial lesions in dogs--a model of breast cancer.
Antuofermo E; Miller MA; Pirino S; Xie J; Badve S; Mohammed SI
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2247-56. PubMed ID: 17982119
[TBL] [Abstract][Full Text] [Related]
46. The combined expression pattern of BMP2, LTBP4, and DERL1 discriminates malignant from benign canine mammary tumors.
Klopfleisch R; Klose P; Gruber AD
Vet Pathol; 2010 May; 47(3):446-54. PubMed ID: 20375427
[TBL] [Abstract][Full Text] [Related]
47. Development, anatomy, histology, lymphatic drainage, clinical features, and cell differentiation markers of canine mammary gland neoplasms.
Sorenmo KU; Rasotto R; Zappulli V; Goldschmidt MH
Vet Pathol; 2011 Jan; 48(1):85-97. PubMed ID: 21147765
[TBL] [Abstract][Full Text] [Related]
48. p63: a novel myoepithelial cell marker in canine mammary tissues.
Gama A; Alves A; Gartner F; Schmitt F
Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513
[TBL] [Abstract][Full Text] [Related]
49. Canine mammary tumours as a model to study human breast cancer: most recent findings.
Queiroga FL; Raposo T; Carvalho MI; Prada J; Pires I
In Vivo; 2011; 25(3):455-65. PubMed ID: 21576423
[TBL] [Abstract][Full Text] [Related]
50. Downregulation of the KLF4 transcription factor inhibits the proliferation and migration of canine mammary tumor cells.
Tien YT; Chang MH; Chu PY; Lin CS; Liu CH; Liao AT
Vet J; 2015 Aug; 205(2):244-53. PubMed ID: 25616642
[TBL] [Abstract][Full Text] [Related]
51. Survivin and related proteins in canine mammary tumors: immunohistochemical expression.
Bongiovanni L; Romanucci M; Malatesta D; D'Andrea A; Ciccarelli A; Della Salda L
Vet Pathol; 2015 Mar; 52(2):269-75. PubMed ID: 24686389
[TBL] [Abstract][Full Text] [Related]
52. Significance of caveolin-1 and matrix metalloproteinase 14 gene expression in canine mammary tumours.
Ebisawa M; Iwano H; Nishikawa M; Tochigi Y; Komatsu T; Endou Y; Hirayama K; Taniyama H; Kadosawa T; Yokota H
Vet J; 2015 Nov; 206(2):191-6. PubMed ID: 26364240
[TBL] [Abstract][Full Text] [Related]
53. Effectiveness of small interfering RNA (siRNA) against the Mcl-1 gene in a canine mammary gland tumor cell line.
Kano R; Yano T; Nagamatsu K; Maruyama H; Kamata H; Hasegawa A
Res Vet Sci; 2009 Aug; 87(1):64-6. PubMed ID: 19185893
[TBL] [Abstract][Full Text] [Related]
54. Molecular biological aspects on canine and human mammary tumors.
Rivera P; von Euler H
Vet Pathol; 2011 Jan; 48(1):132-46. PubMed ID: 21147766
[TBL] [Abstract][Full Text] [Related]
55. Expression of bone morphogenetic protein-6 and bone morphogenetic protein receptors in myoepithelial cells of canine mammary gland tumors.
Akiyoshi T; Uchida K; Tateyama S
Vet Pathol; 2004 Mar; 41(2):154-63. PubMed ID: 15017029
[TBL] [Abstract][Full Text] [Related]
56. Estrogen receptors in canine mammary gland tumours.
Sobczak-Filipiak M; Malicka E
Pol J Vet Sci; 2002; 5(1):1-5. PubMed ID: 11944580
[TBL] [Abstract][Full Text] [Related]
57. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
Gama A; Alves A; Schmitt F
Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
[TBL] [Abstract][Full Text] [Related]
58. RAD51 protein expression is increased in canine mammary carcinomas.
Klopfleisch R; Schütze M; Gruber AD
Vet Pathol; 2010 Jan; 47(1):98-101. PubMed ID: 20080488
[TBL] [Abstract][Full Text] [Related]
59. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence.
Sorenmo KU; Kristiansen VM; Cofone MA; Shofer FS; Breen AM; Langeland M; Mongil CM; Grondahl AM; Teige J; Goldschmidt MH
Vet Comp Oncol; 2009 Sep; 7(3):162-72. PubMed ID: 19691645
[TBL] [Abstract][Full Text] [Related]
60. Immunohistochemical detection of progesterone and cellular proliferation in canine mammary tumours.
Thuróczy J; Reisvaag GJ; Perge E; Tibold A; Szilágyi J; Balogh L
J Comp Pathol; 2007; 137(2-3):122-9. PubMed ID: 17645888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
